Aclaris Investigational Site

Austin, Texas 78759

0 studies enrolling now · 9 studies all time

What they study most

Alopecia, Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Atopic Dermatitis, Common Wart, Seborrheic Keratosis

Studies at this site

• Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed
• Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis — Completed
• A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution — Completed
• Safety Study of A-101 Topical Solution for the Treatment of Common Warts — Completed
• ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) — Stopped early
• Study of A-101 Topical Solution for the Treatment of Common Warts — Completed
• ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis — Completed
• An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses — Completed
• A Phase2 of A-101 Topical Solution in Subjects With Common Warts — Completed